DPP4 and Abnormal renal physiology: Although we found an increased risk of acute kidney injury when comparing DPP4 inhibitor and metformin initiators, this comparison is highly susceptible to confounding by indication given metformin’s place in therapy and contraindication in patients with renal dysfunction.